Medicine News and Research

RSS

Researchers take step toward restoring natural, high-fidelity vision to blind people

In laboratory tests, researchers have used electrical stimulation of retinal cells to produce the same patterns of activity that occur when the retina sees a moving object. Although more work remains, this is a step toward restoring natural, high-fidelity vision to blind people, the researchers say.

6 Jun 2014

University of Texas professor to receive Robert K. Chalmers Distinguished Pharmacy Educator Award

The American Association of Colleges of Pharmacy will honor Robert L. Talbert, Pharm.D., B.S., professor of pharmacotherapy in the College of Pharmacy at The University of Texas at Austin, for his excellence as a teacher, his outstanding achievements as an author and mentor, and his overall impact on pharmacy education and the profession.

6 Jun 2014

ImStem successfully treats animal model of multiple sclerosis using hESC

ImStem Biotechnology, Inc. (ImStem) announced today it has successfully treated an animal model of multiple sclerosis (MS) using human embryonic stem cells (hESC) derived mesenchymal stem cells (MSCs), called hES-MSCs.

6 Jun 2014

Viewpoints: The case for doctors making house calls; the measles threat; the VA's value

At a time when burdensome restrictions enacted in Republican-led states are threatening women's access to abortion care, it is all the more vital that courts scrutinize phony claims that new laws actually protect women's health and safety (Dorothy J. Samuels, 6/4).

6 Jun 2014

Risk factors for violence and death are not restricted to schizophrenia

Drug-use disorders, criminality and self-harm increase the risk for violent crime and premature death not only in patients with schizophrenia, but also in their unaffected siblings, researchers report.

5 Jun 2014

Patients and families benefit from shorter TB treatment regimens

Shorter TB treatment regimens will reduce the out-of-pocket expenses incurred by both patients and their family members, who often act as the patients' guardians. In addition, shorter TB regimens may allow an earlier return to productive activities for patients and their families.

5 Jun 2014

CBO to stop scoring some parts of the health law

The congressional budget analysts announce that they will continue to track the financial impact of the marketplaces and the Medicaid expansion program, but not some of the other smaller changes made under the law. Meanwhile, a new strategy for employers who provide health care is coming under scrutiny.

5 Jun 2014

Naloxegol holds hope for opioid-induced constipation

Pain medicines often lead to constipation for patients seeking long-term pain relief, but an investigational once-daily drug may help, according to study led by the University of Michigan Health System.

5 Jun 2014

Navigated brain stimulation system may help improve motor function for people recovering from stroke

Researchers at Shepherd Center are studying whether stimulating the brain before rehabilitation could yield greater gains in motor function for people recovering from stroke.

5 Jun 2014

Team Type 1 Foundation awards scholarships to student athletes with type 1 diabetes

The Team Type 1 Foundation, a nonprofit organization pursuing a global mission of education, empowerment and equal access to medicine for everyone affected by diabetes, will award $5,000 scholarships to seven student athletes for the 2014-15 academic year as part of the Foundation's inaugural "Global Ambassador Program" recognizing young, talented athletes with type 1 diabetes who are using their sport as a platform to inspire.

5 Jun 2014

Researchers examine how residential environment impacts birth outcomes in African-Americans

High levels of racial disparities in preterm delivery exist, with African Americans having higher rates than non-Hispanic whites. Since traditional risk factors do not fully account for this disparity, other explanations are needed and researchers at Wayne State University are teaming up to find answers.

5 Jun 2014

NEJM publishes results from SOLO I Phase 3 clinical trial of ORBACTIV for ABSSSI

The Medicines Company today announced the publication of the results from the SOLO I Phase 3 clinical trial of ORBACTIV (oritavancin), an investigational intravenous antibiotic treatment for Acute Bacterial Skin and Skin Structure Infections (ABSSSI), in the New England Journal of Medicine.

5 Jun 2014

Palliative support services help caregivers of patients with advanced cancer

Dartmouth researchers have found that those caring for patients with advanced cancer experienced reduced depression and felt less burdened by caregiving tasks when palliative support services were offered soon after the patient's diagnosis.

5 Jun 2014

New single-dose antibiotic is as effective as twice-daily infusion given for up to 10 days

In the battle against stubborn skin infections, including methicillin-resistant Staphylococcus aureus (MRSA), a new single-dose antibiotic is as effective as a twice-daily infusion given for up to 10 days, according to a large study led by Duke Medicine researchers.

5 Jun 2014

Gamma and neutron imaging safe and effective in simulations

Gamma and neutron imaging offer possible improvements over existing techniques such as X-ray or CT, but their safety is not yet fully understood.

5 Jun 2014

Disinfection caps reduce CLABSI events by 68%

Thanks to the simple use of an alcohol-impregnated cap, Loyola University Medical Center achieved a 68 percent decrease in the overall number of central line-associated bloodstream infections (CLABSI) over a 12-month period.

5 Jun 2014

Klinikverbund Kempten-Oberallgäu selects iMDsoft's MetaVision to manage patient information

iMDsoft, a leader in clinical information systems, announced that Klinikverbund Kempten-Oberallgäu in Germany, a hospital with four sites in Kempten, Immenstadt, Oberstdorf and Sonthofen, chose MetaVision for all of its ICUs, intermediate care units and operating rooms.

5 Jun 2014

Discovery of IDE may lead to new treatment approaches for diabetes

The discovery of an inhibitor of the Insulin Degrading Enzyme (IDE), a protein responsible for the susceptibility of diabetes because it destroys insulin in the body, may lead to new treatment approaches for diabetes.

5 Jun 2014

Loyola achieves 68% decrease in central line-associated bloodstream infections

Loyola University Medical Center achieved a 68 percent decrease in the overall number of central line-associated bloodstream infections (CLABSI) over a 12-month period. A two-year study compared the use of disinfection caps to an intense scrub-the-hub intervention to standard care. Scrub-the-hub refers to cleaning catheter connector hubs and injection ports with alcohol for the recommended 15 seconds before accessing the central line, a catheter placed in a large vein to deliver medicine and liquids during hospitalization.

5 Jun 2014

Kelley Thompson selected to receive 2014 PCFSN Community Leadership Award

The President's Council on Fitness, Sports & Nutrition (PCFSN) has selected Kelley Thompson to receive a 2014 PCFSN Community Leadership Award. The award is given to individuals and organizations who significantly improve the lives of others through sports, fitness or nutrition-related programs within local neighborhoods.

5 Jun 2014

Medicine News and Research

Researchers take step toward restoring natural, high-fidelity vision to blind people

University of Texas professor to receive Robert K. Chalmers Distinguished Pharmacy Educator Award

ImStem successfully treats animal model of multiple sclerosis using hESC

Viewpoints: The case for doctors making house calls; the measles threat; the VA's value

Risk factors for violence and death are not restricted to schizophrenia

Patients and families benefit from shorter TB treatment regimens

CBO to stop scoring some parts of the health law

Naloxegol holds hope for opioid-induced constipation

Navigated brain stimulation system may help improve motor function for people recovering from stroke

Team Type 1 Foundation awards scholarships to student athletes with type 1 diabetes

Researchers examine how residential environment impacts birth outcomes in African-Americans

NEJM publishes results from SOLO I Phase 3 clinical trial of ORBACTIV for ABSSSI

Palliative support services help caregivers of patients with advanced cancer

New single-dose antibiotic is as effective as twice-daily infusion given for up to 10 days

Gamma and neutron imaging safe and effective in simulations

Disinfection caps reduce CLABSI events by 68%

Klinikverbund Kempten-Oberallgäu selects iMDsoft's MetaVision to manage patient information

Discovery of IDE may lead to new treatment approaches for diabetes

Loyola achieves 68% decrease in central line-associated bloodstream infections

Kelley Thompson selected to receive 2014 PCFSN Community Leadership Award

Everything there is to know about biosimilars eBook

Improving healthcare sustainability through carbon data

Managing vibration in IVF laboratories

A New Approach to Preventing Bladder Cancer Recurrence

Latest News